CTSO
Cytosorbents Crp
3.70$
-3.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -36.5% | +17,991.8% | -76.7% | +322.0% | -33.9% | -19.1% | +17.1% | +57.3% | +21.2% | +109.3% | +32.9% | -13.9% | +148.6% | +35.9% | -16.4% | +228.5% | -0.5% | -29.4% | -15.8% | -11.1% | -6.7% | |
| – | -45.2% | +52,773.9% | -85.8% | +643.6% | -35.9% | -28.7% | +21.2% | +73.2% | +18.6% | +118.2% | +29.6% | -20.6% | +164.9% | +36.3% | -26.0% | +294.5% | -22.0% | -47.5% | -23.9% | -15.9% | -4.5% | |
| – | -57.8% | +68,000.0% | -92.6% | +1,199.2% | -42.0% | -33.8% | +12.4% | +45.7% | +26.2% | +65.1% | +47.5% | -1.3% | +230.2% | +29.1% | -45.3% | +483.8% | -27.0% | -57.5% | -36.2% | -76.8% | +90.5% | |
| – | – | +68,000.0% | -92.6% | +1,293.5% | -45.9% | -33.8% | +12.4% | +45.7% | +26.2% | +154.2% | +35.3% | -30.1% | +230.2% | +29.1% | -45.3% | +483.8% | -27.0% | -57.5% | -36.2% | -76.8% | +90.5% | |
| – | – | – | – | – | – | – | – | +43.5% | +774.9% | +80.8% | -20.8% | +120.9% | +53.9% | +78.8% | +13.3% | +15.5% | -12.3% | +25.2% | +6.9% | +20.8% | +3.1% | |
| – | – | – | – | – | – | – | – | +58.3% | -64.0% | +119.0% | +121.3% | -30.0% | -4.6% | +4.7% | +153.7% | +26.5% | +78.3% | -27.4% | +6.3% | -25.7% | +93.2% | |
| – | – | – | – | – | – | +657.9% | +7.6% | -5.8% | -1.1% | +70.4% | +126.5% | +2.2% | +146.4% | +126.6% | -5.8% | -29.2% | +776.2% | -42.2% | – | – | – | |
| – | – | – | – | +5.6% | -2.1% | +6.4% | +27.8% | -23.2% | +73.9% | +54.7% | +38.4% | +54.3% | +54.3% | +42.8% | +28.0% | +25.6% | – | – | – | – | – | |
| – | – | – | – | +5.6% | -2.1% | +6.4% | +27.8% | -23.2% | +73.9% | +54.7% | +38.4% | +54.3% | +54.3% | +42.8% | +28.0% | +25.6% | +11.4% | -6.6% | -11.0% | -4.1% | -13.9% | |
| – | +13.3% | +961.1% | -16.2% | +13.3% | -5.5% | +136.6% | -21.4% | +729.4% | +22.4% | -75.4% | -32.5% | +234.1% | +36.1% | +14.2% | +51.6% | -55.2% | +151.0% | +3.4% | +7.6% | +20.9% | +5.6% | |
| – | +15.0% | +1,076.5% | -16.2% | +7.8% | -0.7% | +25.6% | +25.3% | +35.9% | +47.6% | +47.0% | -32.5% | +100.1% | +28.9% | -16.7% | +52.0% | +2.2% | +34.8% | -29.0% | +49.7% | -32.5% | -1.2% | |
| – | – | – | – | – | – | – | – | +214.7% | +77.5% | -49.8% | -20.5% | +27.1% | +380.0% | -83.3% | +278.4% | -82.3% | +27.5% | -80.9% | +2,537.8% | -84.2% | +19.5% | |
| – | – | +2,529.5% | -17.7% | +14.2% | -3.8% | -4.0% | -17.4% | +18.6% | -1.8% | -11.2% | -2.0% | +94.3% | -6.4% | +58.0% | +3.7% | +21.0% | +13.7% | -41.0% | +129.7% | -12.2% | -14.1% | |
| – | – | – | – | – | – | – | -74.3% | -100.0% | – | – | – | – | +46.9% | +54.8% | +44.3% | – | – | – | -49.1% | +450.4% | +19.1% | |
| – | – | – | -104.4% | – | -46.3% | -138.2% | – | -3,751.8% | – | – | +107.2% | -105.8% | – | +65.0% | -79.8% | +2,217.6% | -21.0% | -43.5% | -34.2% | -52.3% | -46.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -95.0% | +214.3% | +2.0% | +1.1% | +65.6% | +135.8% | +63.3% | +23.7% | +19.1% | +52.3% | +73.0% | +2.2% | +8.6% | +2,124.9% | -94.7% | +20.3% | +11.7% | +0.5% | +2.5% | +21.9% | +14.3% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.